Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Oncology Letters|September 21, 2017
T-cadherin is associated with prognosis in triple-negative breast cancerDe-Di Kong, Mei-Hong Wang, Jie Yang, et al.Breast Cancer Research and Treatment|February 14, 2015
T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancerDe-di Kong, Jie Yang, Liang Li, et al.Pediatrics and Neonatology|December 6, 2008
Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathyShi-Bing Wang, Wen-Chin Weng, Ni-Chung Lee, et al.Human Pathology|August 7, 2018
The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinomaYing-Yu Ma, Guo-Hai Zhang, Jingjing Li, et al.Biotechnology Letters|April 18, 2019
Recent advances in carbohydrate-based cancer vaccinesKe-Tao Jin, Huan-Rong Lan, Xiao-Yi Chen, et al.Applied Microbiology and Biotechnology|August 21, 2020
The limiting factors of oncolytic virus immunotherapy and the approaches to overcome themPei-Yang Hu, Xiao-Ming Fan, You-Ni Zhang, et al.Biotechnology Letters|March 14, 2020
Recent advances in targeting cancer stem cells using oncolytic virusesYou-Ni Zhang, Shi-Bing Wang, Shu-Shu Song, et al.Contrast Media & Molecular Imaging|November 4, 2017
Molecular Imaging of Cancer with Nanoparticle-Based Theranostic ProbesYing-Yu Ma, Ke-Tao Jin, Shi-Bing Wang, et al.Oncotarget|February 10, 2018
Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathwayYue-Xing Tu, Shi-Bing Wang, Luo-Qin Fu, et al.Immunology Letters|February 26, 2020
Immune-mediated adverse effects of immune-checkpoint inhibitors and their management in cancerKe-Tao Jin, Shi-Bing Wang, Xiao-Jiang Ying, et al.Pageof 4